
Leidos Hld (LDOS) Stock Forecast & Price Target
Leidos Hld (LDOS) Analyst Ratings
Bulls say
Leidos Holdings Inc. has demonstrated strong financial performance, particularly in its Health & Civil segment, which has benefited from increased exam volumes, driving significant margin improvements. The company's National Security revenues rose by 8% year-over-year to $2.02 billion, exceeding analyst expectations, while Defense Systems revenues grew by 11% year-over-year to $582 million, reflecting robust demand in key areas. Notably, EBIT margins have shown remarkable growth, jumping from 14.5% in 2023 to 22.5% in 2024, with 1H25 margins reaching an impressive 24.3%, indicating a positive financial outlook going forward.
Bears say
Leidos Holdings Inc. faces a challenging financial outlook due to anticipated margin declines, particularly in the second half of 2025 compared to the first half, signaling potential pressure on profitability. Concerns surrounding a decrease in medical exam volumes and risks from budgetary fluctuations could further exacerbate margin contraction, thereby negatively impacting investor sentiment. Additionally, external factors such as legal challenges related to significant contract wins and uncertainties in future defense spending, alongside risks from international operations and potential government shutdowns, complicate the company's financial stability.
This aggregate rating is based on analysts' research of Leidos Hld and is not a guaranteed prediction by Public.com or investment advice.
Leidos Hld (LDOS) Analyst Forecast & Price Prediction
Start investing in Leidos Hld (LDOS)
Order type
Buy in
Order amount
Est. shares
0 shares